ð¡è³åäžãªã¹ã¯ã¯å€åããïŒ4幎éã®è¿œè·¡èª¿æ»ã§åãã£ã3ã€ã®ãªã¹ã¯æšç§»ãã¿ãŒã³ãšäºé²ã®ãã³ã
è³åäžã¯ãäžçäžã§æ»äº¡ãšé害ã®äž»èŠãªåå ã§ããç¶ããŠããŸããç¹ã«äžåœã§ã¯ããã®è² æ ããŸããŸãå¢å€§ããŠããããšãææãããŠããŸãããããŸã§ã®è³åäžãªã¹ã¯è©äŸ¡ã¯ãå€ãã®å Žåãããäžç¹ã®æž¬å®å€ã«åºã¥ããŠè¡ãããéçãªãã®ã§ããããããã人ã®å¥åº·ç¶æ ãçæŽ»ç¿æ £ã¯æéãšãšãã«å€åããããããªã¹ã¯ããŸãå€åããå¯èœæ§ããããŸãããã®ç ç©¶ã¯ãäžåœã®æäººã察象ã«ãè³åäžãªã¹ã¯ã4幎éã§ã©ã®ããã«å€åãããã远跡ãããã®å€æ§ãªãã¿ãŒã³ïŒè»è·¡ïŒãç¹å®ãããšãšãã«ãããããã®è»è·¡ã«åœ±é¿ãäžããèŠå ãæããã«ããããšãç®çãšããŠããŸãã
ðç ç©¶æŠèŠïŒè³åäžãªã¹ã¯ã®ãå€åãã«çç®
è³åäžã¯ãè³ã®è¡ç®¡ãè©°ãŸã£ããç Žãããããããšã§ãè³ã«è¡æ¶²ãå±ããªããªããè³çްèããã¡ãŒãžãåããç æ°ã§ããäžåºŠçºçãããšãéãåŸéºçãæ®ã£ãããåœã«é¢ããããšãå°ãªããããŸããããã®ç ç©¶ã¯ãåŸæ¥ã®ãçŸæç¹ã§ã®ãªã¹ã¯ããè©äŸ¡ããã ãã§ãªãããå°æ¥çã«ãªã¹ã¯ãã©ãå€åããŠãããããšããèŠç¹ã«ç«ã¡ãè³åäžäºé²ã®ããã®æ°ããªã¢ãããŒããæ¢ããã®ã§ããç¹ã«ããªã¹ã¯ãäžæåŸåã«ãã人ã ãæ©æã«ç¹å®ãããã广çãªä»å ¥ãè¡ãããã®æããããèŠã€ããããšãç®æããŸããã
ð¬ç ç©¶æ¹æ³ïŒ1,376人ã4幎é远跡
æ¬ç ç©¶ã§ã¯ãäžåœã®ãåœå®¶è³åäžã¹ã¯ãªãŒãã³ã°ã»ä»å ¥ããã°ã©ã ãã®ããŒã¿ãå©çšããŸããããã®ããã°ã©ã ã«åå ãã1,376äººã®æäººã察象ã«ã2018幎ã2020幎ã2022幎ã®3åã«ããã£ãŠå¥åº·ç¶æ ã远跡調æ»ããŸããã
è³åäžãªã¹ã¯ã®æšç§»ãåæããããã«ããGroup-based trajectory modelingïŒGBTMïŒããšããçµ±èšææ³ãçšããããŸãããããã¯ãéå£å ã®å人ãæéãšãšãã«ã©ã®ããã«å€åãããããããã€ãã®ç°ãªããã¿ãŒã³ïŒè»è·¡ïŒã«åé¡ããææ³ã§ããå ·äœçã«ã¯ã环ç©ãªã¹ã¯ã¹ã³ã¢ã«åºã¥ããŠãåå è ãããããã©ã®ãªã¹ã¯è»è·¡ã«å±ããããç¹å®ããŸããã
ããã«ãããŒã¹ã©ã€ã³æïŒç ç©¶éå§æïŒã®äººå£çµ±èšåŠçèŠå ïŒå¹Žéœ¢ãªã©ïŒãã©ã€ãã¹ã¿ã€ã«èŠå ïŒé£²é ç¿æ £ãé£ç掻ãªã©ïŒãå¥åº·é¢é£èŠå ïŒãŠãšã¹ãåšå²åŸããã¢ã·ã¹ãã€ã³å€ãªã©ïŒããã©ã®ãªã¹ã¯è»è·¡ã°ã«ãŒãã«å±ããããšã©ã®ããã«é¢é£ããŠããããããå€é ããžã¹ãã£ãã¯ååž°åæããšããçµ±èšææ³ã§è©äŸ¡ããŸãããããã¯ãè€æ°ã®ã«ããŽãªãŒãæã€çµæïŒãã®å Žåã¯3ã€ã®ãªã¹ã¯è»è·¡ã°ã«ãŒãïŒãšãããã«åœ±é¿ãäžããèŠå ãšã®é¢ä¿ãåæããææ³ã§ãã
ðäž»ãªç ç©¶çµæïŒ3ã€ã®ãªã¹ã¯è»è·¡ãšé¢é£èŠå
ãã®ç ç©¶ã«ãããäžåœã®æäººã«ãããè³åäžãªã¹ã¯ã®æšç§»ã«ã¯ãäž»ã«ä»¥äžã®3ã€ã®ç°ãªããã¿ãŒã³ïŒè»è·¡ïŒãããããšãæããã«ãªããŸããã
| ãªã¹ã¯è»è·¡ã°ã«ãŒã | ç¹åŸŽ | å²å |
|---|---|---|
| å®å®ããäœãªã¹ã¯çŸ€ | 4幎éãéããŠè³åäžãªã¹ã¯ãäœãç¶æ ãç¶æããŠããã°ã«ãŒãã | 41.42% |
| ãªã¹ã¯å¢å 矀 | ç ç©¶æéäžã«è³åäžãªã¹ã¯ãåŸã ã«äžæããŠããåŸåãèŠãããã°ã«ãŒãã | 41.21% |
| å®å®ããé«ãªã¹ã¯çŸ€ | 4幎éãéããŠè³åäžãªã¹ã¯ãé«ãç¶æ ãç¶æããŠããã°ã«ãŒãã | 17.37% |
ãããã®3ã€ã®ã°ã«ãŒãéã§ã¯ãç ç©¶éå§æïŒããŒã¹ã©ã€ã³ïŒã®äººå£çµ±èšåŠçèŠå ãã©ã€ãã¹ã¿ã€ã«ãå¥åº·é¢é£èŠå ã«ææãªéããèŠãããŸããã
å€é ããžã¹ãã£ãã¯ååž°åæã®çµæã以äžã®èŠå ãããªã¹ã¯å¢å 矀ãããã³ãå®å®ããé«ãªã¹ã¯çŸ€ããžç§»è¡ããå¯èœæ§ãé«ãããšãšææã«é¢é£ããŠããããšã倿ããŸããã
é«éœ¢
é »ç¹ãªå€é飲é
èé£äž»çŸ©ã®å¥œã¿ïŒâ»ãã®ç ç©¶ã§ã¯èé£äž»çŸ©ããªã¹ã¯èŠå ãšããŠæããããŠããŸãããããã¯é£ç掻å
šäœã®ãã©ã³ã¹ãæ é€çŽ ã®åãã圱é¿ããŠããå¯èœæ§ããããäžè¬çã«èé£äž»çŸ©ãè³åäžãªã¹ã¯ãé«ãããšããæå³ã§ã¯ãããŸãããç¹å®ã®æ é€çŽ ã®äžè¶³ãå å·¥é£åã®æåãå€ãå Žåãªã©ãèããããŸããïŒ
倧ããªãŠãšã¹ãåšå²åŸ
é«ããã¢ã·ã¹ãã€ã³å€ïŒãã¢ã·ã¹ãã€ã³ã¯ãäœå
ã§çæãããã¢ããé
žã®äžçš®ã§ãé«å€ãç¶ããšè¡ç®¡ã«ãã¡ãŒãžãäžããè³åäžãå¿èç
ã®ãªã¹ã¯ãé«ããå¯èœæ§ããããšãããŠããŸããïŒ
ð€èå¯ïŒæ©æä»å ¥ã®éèŠæ§
ãã®ç ç©¶ã¯ãè³åäžãªã¹ã¯ãåäžã®éçãªç¶æ ã§ã¯ãªããæéãšãšãã«å€æ§ãªãã¿ãŒã³ã§å€åãããšããéèŠãªç¥èŠããããããŸãããç¹ã«ãããªã¹ã¯å¢å 矀ããç¹å®ã§ããããšã¯ãè³åäžäºé²ã«ãããŠéåžžã«å€§ããªæå³ãæã¡ãŸãããªããªãããã®ã°ã«ãŒãã®äººã ã¯ããŸã è³åäžãçºçããŠããªã段éã§ãªã¹ã¯ãäžæããŠããããšãããããããæ©æã«ä»å ¥ããããšã§çºçãæªç¶ã«é²ãããããã¯é ãããæ©äŒãæäŸã§ããããã§ãã
ç ç©¶ã§ç¹å®ããããªã¹ã¯èŠå ïŒé«éœ¢ãé »ç¹ãªå€é飲é ãç¹å®ã®é£ç掻ã倧ããªãŠãšã¹ãåšå²åŸãé«ãã¢ã·ã¹ãã€ã³å€ïŒã¯ãããããçæŽ»ç¿æ £ãšå¯æ¥ã«é¢é£ããŠããŸãããããã®èŠå ã«æ³šç®ããåã ã®ãªã¹ã¯è»è·¡ã«åããããããçãçµã£ãäºé²æŠç¥ãç«ãŠãããšã§ãè³åäžã®çºççã广çã«æžå°ãããããšãã§ãããããããŸããã
äŸãã°ã宿çãªå¥åº·èšºæã§ãã¢ã·ã¹ãã€ã³å€ãé«ããšå€æãã人ãããŠãšã¹ãåšå²åŸãå¢å åŸåã«ãã人ã«å¯ŸããŠãããç©æ¥µçãªçæŽ»ç¿æ £æ¹åã®ã¢ããã€ã¹ãå»ççãªãµããŒããæäŸããããšãèããããŸãããã®ããã«ããªã¹ã¯ã®ãæšç§»ããææ¡ããã¢ãããŒãã¯ãåŸæ¥ã®éçãªãªã¹ã¯è©äŸ¡ã«æ¯ã¹ãŠãããããŒãœãã©ã€ãºãããäºé²å»çã®å®çŸã«è²¢ç®ããå¯èœæ§ãç§ããŠããŸãã
ðââïžå®ç掻ã§ã§ããããšïŒè³åäžäºé²ã®ã¢ããã€ã¹
ãã®ç ç©¶çµæãèžãŸããç§ãã¡ãæ¥ã ã®ç掻ã®äžã§è³åäžãªã¹ã¯ãæžããããã«ã§ããããšã¯ãããããããŸãã
å¥åº·çãªé£ç掻ãå¿ãããïŒ
éèãæç©ãç©æ¥µçã«æåããé£ç©ç¹ç¶ãè±å¯ã«æããŸãããã
å¡©åã飜åèèªé
žã®æåãæ§ããã«ããå å·¥é£åããã¡ã¹ãããŒãã®æåãæžãããŸãããã
å
šç²ç©ç©ãéãè±é¡ãªã©ããã©ã³ã¹è¯ãåãå
¥ããŸãããã
é©åºŠãªéåãç¿æ
£ã«ããïŒ
ãŠã©ãŒãã³ã°ããžã§ã®ã³ã°ãæ°Žæ³³ãªã©ãç¡çãªãç¶ããããæé
žçŽ éåãé±ã«150å以äžç®æããŸãããã
座ãã£ã±ãªãã®æéãæžãããããŸãã«äœãåããããšãæèããŸãããã
çŠç
ã»ç¯é
ã培åºããïŒ
å«ç
ã¯è³åäžãªã¹ã¯ã倧å¹
ã«é«ããŸããçŠç
ã¯æã广çãªäºé²çã®äžã€ã§ãã
é床ãªé£²é
ã¯é¿ããé©éãå®ããŸããããç¹ã«é »ç¹ãªå€é飲é
ã¯ãªã¹ã¯ãé«ããŸãã
äœé管çãšãŠãšã¹ãåšå²åŸã®ãã§ãã¯ïŒ
è¥æºã¯é«è¡å§ãç³å°¿ç
ãè質ç°åžžçãªã©ã®ãªã¹ã¯ãé«ããè³åäžã«ã€ãªãããŸãã驿£äœéãç¶æããŸãããã
ç¹ã«ãŠãšã¹ãåšå²åŸã倧ãããå
èèèªåè¥æºãã¯æ³šæãå¿
èŠã§ãã宿çã«æž¬å®ããç®æšå€ãèšå®ããŸãããã
宿çãªå¥åº·èšºæãšãªã¹ã¯èŠå ã®ç®¡çïŒ
è¡å§ãè¡ç³å€ãã³ã¬ã¹ãããŒã«å€ããããŠãã¢ã·ã¹ãã€ã³å€ãªã©ãè³åäžã«é¢é£ããå¥åº·ææšã宿çã«ãã§ãã¯ããŸãããã
ç°åžžãèŠã€ãã£ãå Žåã¯ãå»åž«ã®æå°ã®ããšãé©åãªæ²»çãçæŽ»ç¿æ
£ã®æ¹åãè¡ããŸãããã
ã¹ãã¬ã¹ãäžæã«ç®¡çããïŒ
ã¹ãã¬ã¹ã¯è¡å§äžæãªã©ãè³åäžãªã¹ã¯ãé«ããèŠå ãšãªãåŸãŸãããªã©ãã¯ã¹ããæéãäœããè¶£å³ãéåãªã©ã§ã¹ãã¬ã¹ãçºæ£ããŸãããã
ð§ç ç©¶ã®éçãšä»åŸã®èª²é¡
æ¬ç ç©¶ã¯éèŠãªç¥èŠããããããŸããããããã€ãã®éçãååšããŸãã
察象å°åã®é宿§ïŒ äžåœã®ç¹å®ã®å°åã³ããŒãã察象ãšããŠãããããä»ã®åœãå°åãç°ãªãæ°æéå£ã«ãã®ãŸãŸçµæãäžè¬åã§ãããšã¯éããŸããã
远跡æéïŒ 4幎éã®è¿œè·¡æéã¯ãè³åäžãšããé·æçãªçŸæ£ã®ãªã¹ã¯æšç§»ãå®å
šã«æããã«ã¯ãŸã çãå¯èœæ§ããããŸããããé·æçãªè¿œè·¡èª¿æ»ãæãŸããŸãã
ããŒã¿åéæ¹æ³ïŒ äžéšã®ããŒã¿ã¯èªå·±ç³åã«åºã¥ããŠããå¯èœæ§ããããèšæ¶ã®åããå ±åã®æ£ç¢ºæ§ã«åœ±é¿ãäžããå¯èœæ§ããããŸãã
ä»å
¥ç ç©¶ã®å¿
èŠæ§ïŒ ä»åã®ç ç©¶ã¯èгå¯ç ç©¶ã§ãããç¹å®ããããªã¹ã¯èŠå ãè»è·¡ã«å¯Ÿããä»å
¥ãå®éã«è³åäžçºçãæžå°ããããã©ããã¯ãä»åŸã®ä»å
¥ç ç©¶ã§æ€èšŒããå¿
èŠããããŸãã
ãããã®éçãèžãŸããä»åŸã¯ãã倿§ãªéå£ã察象ãšããé·æçãªç ç©¶ããç¹å®ããããªã¹ã¯è»è·¡ã«å¯Ÿããåå¥åãããä»å ¥ã®å¹æãæ€èšŒããç ç©¶ãæ±ããããŸãã
ãŸãšãïŒè³åäžäºé²ã¯ãå€åããæããæä»£ãž
ãã®ç ç©¶ã¯ãè³åäžãªã¹ã¯ãæéãšãšãã«å€æ§ãªè»è·¡ããã©ãããšãæç¢ºã«ç€ºããŸãããç¹ã«ããªã¹ã¯ãäžæåŸåã«ãã人ã ãæ©æã«ç¹å®ãããã®äººã ã«åãããåå¥åãããäºé²æŠç¥ãç«ãŠãããšã®éèŠæ§ã匷調ãããŠããŸããé«éœ¢ãé »ç¹ãªå€é飲é ãç¹å®ã®é£ç掻ã倧ããªãŠãšã¹ãåšå²åŸãé«ãã¢ã·ã¹ãã€ã³å€ãšãã£ãèŠå ãããªã¹ã¯å¢å ãé«ãªã¹ã¯ç¶æ ã®ç¶æã«é¢é£ããŠããããšãæããã«ãªã£ãããšã§ããããã®èŠå ã«çŠç¹ãåœãŠãäºé²ä»å ¥ã®æå¹æ§ãæåŸ ãããŸããè³åäžäºé²ã¯ãåäžæç¹ã®ãªã¹ã¯è©äŸ¡ãããå人ã®ãªã¹ã¯ã®ãå€åããæããããæ©æãã€ç確ãªã¢ãããŒããè¡ãæä»£ãžãšé²åããŠããã§ããããç§ãã¡äžäººã²ãšããèªèº«ã®å¥åº·ç¶æ ã«æèãåããé©åãªçæŽ»ç¿æ £ãå®è·µããããšããè³åäžãã身ãå®ãããã®éµãšãªããŸãã
ðé¢é£ãªã³ã¯é
åçåŽåç
åœç«åŸªç°åšç
ç ç©¶ã»ã³ã¿ãŒ
æ¥æ¬è³åäžåŠäŒ
äžçä¿å¥æ©é¢ (WHO) – Stroke
åœç«å¥åº·ã»æ é€ç ç©¶æ
æžèªæ å ±
| DOI | 10.1186/s12889-026-27939-4 |
|---|---|
| PMID | 42243802 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42243802/ |
| çºè¡å¹Ž | 2026 |
| èè å | He Xiaoci, Zhao Shuping, He Xiaomeng, Li Feng, Wang Qian, Gao Xu |
| èè æå± | Stroke Screening and Prevention Office, Hebei Cardiovascular and Cerebrovascular Disease Prevention Office, Hebei Engineering Research Center of Medical Microbiome and Clinical Translation, Department of Health Management, the Second Hospital of Hebei Medical University, Shijiazhuang, China.; Department of Gastroenterology, Hebei Engineering Research Center of Medical Microbiome and Clinical Translation, the Second Hospital of Hebei Medical University, Shijiazhuang, China.; Hebei Reproductive Health Hospital, Hebei Maternal and Child Health Hospital, Shijiazhuang, China.; Health Checkup Center, Hebei Engineering Research Center of Medical Microbiome and Clinical Translation, the Second Hospital of Hebei Medical University, Shijiazhuang, China.; Department of Pediatric Urology, Hebei Children's Hospital, Shijiazhuang, Hebei, China. 460134717@qq.com. |
| éèªå | BMC Public Health |